Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.
View Top Employees from Glenmark PharmaceuticalsLooking for a particular Glenmark Pharmaceuticals employee's phone or email?
The Glenmark Pharmaceuticals annual revenue was $1.47 billion in 2024.
9,311 people are employed at Glenmark Pharmaceuticals.
Glenmark Pharmaceuticals is based in Mumbai, Maharashtra.
The NAICS codes for Glenmark Pharmaceuticals are [32541, 32, 325, 3254].
The SIC codes for Glenmark Pharmaceuticals are [28, 2834, 283].